comprehensive -WSS

comprehensive

author：comprehensive 2025-09-06 03:28:31 - browse：2

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Readout LOUD podcast: ALS dilemma, first MASH drug, and more

explore

WSS

Supreme Court to hear if Covid misinformation is protected speech

Supreme Court to hear if Covid misinformation is protected speech

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

What a koala virus tells us about the human genome

CVS is willing to dump 10% of its Medicare Advantage members

hotspot

comprehensive

focus

Cancer drug shortages should be causing more outrage

The United States must get value

Hepatitis C has a cure — but many Americans still lack access to it

As H5N1 spreads in cows, experts warn against drinking raw milk

DIEP, the 'gold standard' of breast reconstruction, is under threat

Ebola: Gilead Sciences antiviral shows promise as new treatment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Boston hospital trains restaurant workers on naloxone for overdoses

Tori Bowie and the unacceptable rates of Black maternal death

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

knowledge

UCLA team creates talking throat patch for voice disorders

Lilly’s weekly insulin works as well as daily products, new studies show

WuXi out of biotech trade group, U.S. and China relations to blame

Change Healthcare outage fallout shows need for new oversight

Why scientists need input from humanists on sensitive research

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

explore

explore

hotspot

explore